Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients.

Neuropsychobiology - 1 Jan 2014

Drago Antonio, Monti Barbara, De Ronchi Diana, Serretti Alessandro

Abstract excerpt

BACKGROUND: The genetic background of the antidepressant response to pharmacological treatment in bipolar disorder (BD) remains elusive. This issue is of primary relevance in that the depressive phases of BD are difficult to treat and they are associated with suicide. AIM: We investigated the role of a set of genetic variations (single-nucleotide polymorphisms) harbored by matrix metalloproteinases (MMPs) as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Biomarkers, Pharmacological

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bipolar Disorder

Share to Follow-Up Studies

Share to Homozygote

Share to Matrix Metalloproteinases

Share to Socioeconomic Factors

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 24576976
DOI: 10.1159/000356971
PMCID: PMC4011491

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients.PMID 24576976Read ↗

Pharmacogenetic studies in depression: a proposal for methodologic guidelines.Semantic proximity Read ↗

Clinical and genetic factors associated with suicide in mood disorder patients.Semantic proximity Read ↗

Association study of CREB1 polymorphisms and suicidality in MDD: results from a European multicenter study on treatment resistant depression.Semantic proximity Read ↗

A haplotype of glycogen synthase kinase 3β is associated with early onset of unipolar major depression.Semantic proximity Read ↗

Matrix metalloproteinase-9 gene and bipolar mood disorder.Semantic proximity Read ↗

Expression and Activity of Metalloproteinases in DepressionSemantic proximity Read ↗

Association between genetic variation in the myo-inositol monophosphatase 2 (IMPA2) gene and age at onset of bipolar disorder.Semantic proximity Read ↗

Association between Sirtuin 1 Gene rs10997870 Polymorphism and Suicide Behaviors in Bipolar Disorder.Semantic proximity Read ↗

Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.Semantic proximity Read ↗

The gain-of-function variant in the NLRP3 gene predicts the effectiveness of brief psychotherapy but not the risk of major depression.Semantic proximity Read ↗

SSRIs antidepressant activity is influenced by G beta 3 variants.Semantic proximity Read ↗

Differential diagnosis of unipolar versus bipolar depression by GSK3 levels in peripheral blood: a pilot experimental studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.